Jump to page content
Engineering Impact: Summer 2021

Summer 2021

New electronic diagnostic test sends COVID-19, other pathogen test results to smartphones

by College of Engineering

Detection and Diagnosis

The Institute of Inflammation, Immunology and Infectious Disease at Purdue University has partnered with Cleveland-based technology firm IdentifySensors Biologics to develop a rapid diagnostic platform for detecting pathogens, including SARS-CoV-2, the virus that causes COVID-19.

The platform technology can be easily modified to also detect influenza, Zika, dengue, HIV/AIDS, hepatitis C, Lyme disease, mumps, measles, chickenpox, methicillin-resistant staphylococcus Aureus (MRSA) and foodborne pathogens.

The technology is based on the work of Lia Stanciu, professor of materials engineering at Purdue, who developed the technique of identifying pathogens by their induced distinctive resistance change to electronic materials.

An ASIC chip with an array of sensors

Nano-channel | Perforated MOS sensor

SEM image of the perforated MOS sensor


The researchers are looking for partners to continue developing their technology.

For more information on licensing and other opportunities, contact Matthew Halladay of OTC at mrhalladay@prf.org and mention track code: